Evergreen Hospital Medical Center

Kirkland, Washington 98034

0 studies enrolling now · 14 studies all time

What they study most

Acral Lentiginous Malignant Melanoma, Adenocarcinoma of the Colon, Any Disease Causing Death in the ICU or Within 24 Hours of Discharge From the ICU, COVID-19, Dyskinesia, Drug-Induced, Dyskinesias, Estrogen Receptor-negative Breast Cancer, Excessive Sleepiness, Fibromyalgia, HER2-negative Breast Cancer, Healthy Participants, Hypersomnia

Studies at this site

• SpaceIT Hydrogel System for Perirectal Spacing — Running, not enrolling
• Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer — Completed
• A Study to Learn About the Safety of BIIB122 Tablets and Whether They Can Slow the Worsening of Early-Stage Parkinson's Disease in Adults Between the Ages of 30 and 80 — Completed
• RECOVER-SLEEP: Platform Protocol — Completed
• Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy — Stopped early
• Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction — Completed
• A Study to Assess if BIIB122 Tablets Are Safe and Can Slow Worsening of Early-Stage Parkinson's Disease in Participants With Specific LRRK2 Genetic Variants Between the Ages of 30 and 80 Using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale — Stopped early
• A Study of TAK-071 in People With Parkinson Disease — Completed
• Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects — Completed
• A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness — Completed
• Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer — Completed
• Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma — Stopped early
• Integrating Palliative and Critical Care (IPACC) Study — Completed
• Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia. — Completed